Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 5:13 pm Purchase | 2023-03-05 | 13D | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | New Enterprise Associates 14 L.P. | 102,478,672 10.300% | 3,556,804 (+3.60%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | Partner Fund Management L.P. | 29,061,060 3.000% | -25,597,620 (-46.83%) | Filing History |
| 2023-02-13 2:49 pm Sale | 2023-02-14 | 13G | Adaptimmune Therapeutics PLC ADAP | Capital World Investors | 0 0.000% | -48,016,200 (Position Closed) | Filing History |
| 2023-01-18 06:41 am Purchase | 2022-12-30 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | BAILLIE GIFFORD & CO | 103,019,634 10.480% | 401,082 (+0.39%) | Filing History |
| 2022-12-02 07:33 am Purchase | 2022-11-30 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | BAILLIE GIFFORD & CO | 102,618,552 10.440% | 20,080,440 (+24.33%) | Filing History |
| 2022-05-09 4:51 pm Purchase | 2022-04-28 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | Partner Fund Management L.P. | 54,658,680 5.800% | 54,658,680 (New Position) | Filing History |
| 2022-01-18 07:02 am Purchase | 2021-12-31 | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAPY | BAILLIE GIFFORD & CO | 82,538,112 8.810% | 20,391,432 (+32.81%) | Filing History |